We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+23.97%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$69.6B
AUM Growth
+$8.07B
(+13%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
16.2%
Holding
2,221
New
173
Increased
863
Reduced
913
Closed
183
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Sumitomo Mitsui Financial
SMFG
$170B
| $9.78M | 0.01% |
414,866
+1,994
| +0.5% | +$44.3K |
|
702
10x Genomics
TXG
$9.69B
| $9.59M | 0.01% |
250,121
-361,493
| -59% | -$9.47M |
|
|
KLRA
703
Kailera Therapeutics
KLRA
$1.74B
| $9.56M | 0.01% |
+434,069
| New | +$9.54M |
|
704
InterDigital
IDCC
$8.41B
| $9.56M | 0.01% |
33,754
-1,806
| -5% | -$537K |
|
705
HP
HPQ
$30.5B
| $9.47M | 0.01% |
431,429
+104,659
| +32% | +$2.32M |
|
706
BioMarin Pharmaceuticals
BMRN
$12.5B
| $9.36M | 0.01% |
163,619
+1,522
| +0.9% | +$83.4K |
|
707
Costamare
CMRE
$1.83B
| $9.13M | 0.01% |
650,869
+328,708
| +102% | +$5.39M |
|
708
Life Time Group Holdings
LTH
$9.27B
| $9.1M | 0.01% |
222,934
+1,728
| +0.8% | +$54.8K |
|
709
Coeur Mining
CDE
$20.5B
| $9M | 0.01% |
551,674
-624,367
| -53% | -$11.4M |
|
710
Myriad Genetics
MYGN
$371M
| $8.97M | 0.01% |
1,570,314
-405,852
| -21% | -$1.84M |
|
711
Canadian Imperial Bank of Commerce
CM
$103B
| $8.94M | 0.01% |
77,758
-20,619
| -21% | -$2.26M |
|
712
Stoneridge
SRI
$205M
| $8.89M | 0.01% |
1,214,355
+28,755
| +2% | +$197K |
|
|
HAWK
713
HawkEye 360 Inc
HAWK
$1.62B
| $8.86M | 0.01% |
+438,195
| New | +$12.1M |
|
714
Novartis
NVS
$263B
| $8.83M | 0.01% |
56,351
-76
| -0.1% | -$11.4K |
|
715
C.H. Robinson
CHRW
$18.4B
| $8.82M | 0.01% |
46,825
-7,639
| -14% | -$1.36M |
|
716
TechnipFMC
FTI
$29.4B
| $8.78M | 0.01% |
132,435
-13,489
| -9% | -$955K |
|
717
Globe Life
GL
$13.3B
| $8.75M | 0.01% |
48,977
+888
| +2% | +$139K |
|
718
International Seaways
INSW
$5.34B
| $8.75M | 0.01% |
114,230
+113,148
| +10,457% | +$9.17M |
|
719
indie Semiconductor
INDI
$714M
| $8.71M | 0.01% |
1,940,903
+5,276
| +0.3% | +$21K |
|
720
Kohl's
KSS
$1.85B
| $8.71M | 0.01% |
491,790
+7,396
| +2% | +$110K |
|
721
Bank of Hawaii
BOH
$2.98B
| $8.66M | 0.01% |
106,236
+9,202
| +9% | +$720K |
|
722
Willis Towers Watson
WTW
$29.9B
| $8.65M | 0.01% |
33,109
-5,122
| -13% | -$1.37M |
|
723
Carvana
CVNA
$48.2B
| $8.65M | 0.01% |
131,412
-1,802,728
| -93% | -$127M |
|
724
ARKO Corp
ARKO
$496M
| $8.64M | 0.01% |
+1,076,420
| New | +$7.55M |
|
|
BRSP
725
BrightSpire Capital
BRSP
$561M
| $8.63M | 0.01% |
1,583,821
+45,195
| +3% | +$259K |
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.